FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013976105> ?p ?o ?g. }

• W2013976105 endingPage "1089" @default.
• W2013976105 startingPage "1082" @default.
• W2013976105 abstract "In Brief BACKGROUND: Antiemetics currently in use are not totally effective. Neurokinin-1 receptor antagonists are a new class of antiemetic that have shown promise for chemotherapy-induced nausea and vomiting. This is the first study evaluating the efficacy and tolerability of the neurokinin-1 receptor antagonist, aprepitant, for the prevention of postoperative nausea and vomiting. METHODS: In this multicenter, double-blind trial, we randomly assigned 805 patients receiving general anesthesia for open abdominal surgery to a preoperative dose of aprepitant 40 mg orally, aprepitant 125 mg orally, or ondansetron 4 mg IV. Vomiting, nausea, and use of rescue therapy were assessed over 48 h after surgery. Treatments were compared using logistic regression. RESULTS: Incidence rates for the primary end point (complete response [no vomiting and no use of rescue] over 0–24 h after surgery, tested for superiority of aprepitant) were not different across groups (45% with aprepitant 40 mg, 43% with aprepitant 125 mg, and 42% with ondansetron). The incidence of no vomiting (0–24 h) was higher with aprepitant 40 mg (90%) and aprepitant 125 mg (95%) versus ondansetron (74%) (P < 0.001 for both comparisons), although between-treatment use of rescue and nausea control was not different. Both aprepitant doses also had higher incidences of no vomiting over 0–48 h (P < 0.001). No statistically significant differences were seen among the side effect profiles of the treatments. CONCLUSIONS: Aprepitant was superior to ondansetron for prevention of vomiting in the first 24 and 48 h, but no significant differences were observed between aprepitant and ondansetron for nausea control, use of rescue, or complete response. IMPLICATIONS: Aprepitant and the active comparator ondansetron did not differ for the composite end point of no vomiting and no rescue 0-24 h after major surgery; aprepitant provided better protection against vomiting 0-24 h and 0-48 h." @default.
• W2013976105 created "2016-06-24" @default.
• W2013976105 creator A5003873901 @default.
• W2013976105 creator A5004205084 @default.
• W2013976105 creator A5015537537 @default.
• W2013976105 creator A5015616162 @default.
• W2013976105 creator A5023232051 @default.
• W2013976105 creator A5028379207 @default.
• W2013976105 creator A5042812464 @default.
• W2013976105 creator A5048883914 @default.
• W2013976105 creator A5058958121 @default.
• W2013976105 creator A5060878734 @default.
• W2013976105 creator A5061133224 @default.
• W2013976105 creator A5069849278 @default.
• W2013976105 creator A5091851614 @default.
• W2013976105 date "2007-05-01" @default.
• W2013976105 modified "2023-09-23" @default.
• W2013976105 title "A Randomized, Double-Blind Comparison of the NK1 Antagonist, Aprepitant, Versus Ondansetron for the Prevention of Postoperative Nausea and Vomiting" @default.
• W2013976105 cites W1970239727 @default.
• W2013976105 cites W1971019459 @default.
• W2013976105 cites W1986128686 @default.
• W2013976105 cites W1986286802 @default.
• W2013976105 cites W1996131593 @default.
• W2013976105 cites W1999179893 @default.
• W2013976105 cites W2001468622 @default.
• W2013976105 cites W2001661339 @default.
• W2013976105 cites W2017532912 @default.
• W2013976105 cites W2027206415 @default.
• W2013976105 cites W2031786331 @default.
• W2013976105 cites W2048034228 @default.
• W2013976105 cites W2059413299 @default.
• W2013976105 cites W2067747375 @default.
• W2013976105 cites W2069215198 @default.
• W2013976105 cites W2076585267 @default.
• W2013976105 cites W2077054055 @default.
• W2013976105 cites W2083670498 @default.
• W2013976105 cites W2122633654 @default.
• W2013976105 cites W2133760117 @default.
• W2013976105 cites W2154735290 @default.
• W2013976105 cites W2160759330 @default.
• W2013976105 cites W2338394838 @default.
• W2013976105 doi "https://doi.org/10.1213/01.ane.0000263277.35140.a3" @default.
• W2013976105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17456656" @default.
• W2013976105 hasPublicationYear "2007" @default.
• W2013976105 type Work @default.
• W2013976105 sameAs 2013976105 @default.
• W2013976105 citedByCount "167" @default.
• W2013976105 countsByYear W20139761052012 @default.
• W2013976105 countsByYear W20139761052013 @default.
• W2013976105 countsByYear W20139761052014 @default.
• W2013976105 countsByYear W20139761052015 @default.
• W2013976105 countsByYear W20139761052016 @default.
• W2013976105 countsByYear W20139761052017 @default.
• W2013976105 countsByYear W20139761052018 @default.
• W2013976105 countsByYear W20139761052019 @default.
• W2013976105 countsByYear W20139761052020 @default.
• W2013976105 countsByYear W20139761052021 @default.
• W2013976105 countsByYear W20139761052022 @default.
• W2013976105 countsByYear W20139761052023 @default.
• W2013976105 crossrefType "journal-article" @default.
• W2013976105 hasAuthorship W2013976105A5003873901 @default.
• W2013976105 hasAuthorship W2013976105A5004205084 @default.
• W2013976105 hasAuthorship W2013976105A5015537537 @default.
• W2013976105 hasAuthorship W2013976105A5015616162 @default.
• W2013976105 hasAuthorship W2013976105A5023232051 @default.
• W2013976105 hasAuthorship W2013976105A5028379207 @default.
• W2013976105 hasAuthorship W2013976105A5042812464 @default.
• W2013976105 hasAuthorship W2013976105A5048883914 @default.
• W2013976105 hasAuthorship W2013976105A5058958121 @default.
• W2013976105 hasAuthorship W2013976105A5060878734 @default.
• W2013976105 hasAuthorship W2013976105A5061133224 @default.
• W2013976105 hasAuthorship W2013976105A5069849278 @default.
• W2013976105 hasAuthorship W2013976105A5091851614 @default.
• W2013976105 hasBestOaLocation W20139761051 @default.
• W2013976105 hasConcept C197934379 @default.
• W2013976105 hasConcept C2777170512 @default.
• W2013976105 hasConcept C2778375690 @default.
• W2013976105 hasConcept C2780574406 @default.
• W2013976105 hasConcept C2780580376 @default.
• W2013976105 hasConcept C2780852908 @default.
• W2013976105 hasConcept C2780884295 @default.
• W2013976105 hasConcept C42219234 @default.
• W2013976105 hasConcept C71924100 @default.
• W2013976105 hasConcept C98274493 @default.
• W2013976105 hasConceptScore W2013976105C197934379 @default.
• W2013976105 hasConceptScore W2013976105C2777170512 @default.
• W2013976105 hasConceptScore W2013976105C2778375690 @default.
• W2013976105 hasConceptScore W2013976105C2780574406 @default.
• W2013976105 hasConceptScore W2013976105C2780580376 @default.
• W2013976105 hasConceptScore W2013976105C2780852908 @default.
• W2013976105 hasConceptScore W2013976105C2780884295 @default.
• W2013976105 hasConceptScore W2013976105C42219234 @default.
• W2013976105 hasConceptScore W2013976105C71924100 @default.
• W2013976105 hasConceptScore W2013976105C98274493 @default.
• W2013976105 hasIssue "5" @default.
• W2013976105 hasLocation W20139761051 @default.
• W2013976105 hasLocation W20139761052 @default.
• W2013976105 hasLocation W20139761053 @default.

• next